​

Moleculin Biotech Ownership | Who Owns Moleculin Biotech?

OverviewForecastFinancialsChartTranscripts

Moleculin Biotech Ownership Summary

Moleculin Biotech is owned by 3.69% institutional investors, 2.24% insiders, and 94.07% retail investors. Rockefeller capital management is the largest institutional shareholder, holding 0.09% of MBRX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 0.97% of its assets in Moleculin Biotech shares.

MBRX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMoleculin Biotech3.69%2.24%94.07%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rockefeller capital management14.51K0.09%$7.69K
Tower research capital llc (trc)8.38K0.05%$4.44K
Advisor group43.000.00%$20.00
Moors & cabot---
Wealth dimensions group---
Verus capital partners---
Nbc securities---
Cva family office---
Atlantic union bankshares---
Bogart wealth---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tower research capital llc (trc)8.38K0.00%$4.44K
Rockefeller capital management14.51K-$7.69K
Nbc securities---
Wealth dimensions group---
Moors & cabot---
Bogart wealth---
Verus capital partners---
Cva family office---
Atlantic union bankshares---
Geode capital management---

Top Buyers

HolderShares% AssetsChange
Rockefeller capital management14.51K-14.51K
Tower research capital llc (trc)8.38K0.00%4.46K
Advisor group43.00--
Nbc securities---14.00
North star investment management---17.00

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.25M
Vanguard group---239.92K
Geode capital management---208.21K
Hrt financial lp---115.19K
Citigroup---85.28K

New Positions

HolderShares% AssetsChangeValue
Rockefeller capital management14.51K-14.51K$7.69K

Sold Out

HolderChange
Nbc securities-14.00
North star investment management-17.00
Cva family office-34.00
Bogart wealth-300.00
Atlantic union bankshares-379.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202512-45.45%573,00132.44%347.53%5-58.33%--
Jun 30, 2025224.76%432,658-70.73%21.11%1318.18%--100.00%
Mar 31, 20252110.53%1,478,032218.10%158.69%1122.22%2-60.00%
Dec 31, 20241911.76%464,6500.89%138.78%912.50%566.67%
Sep 30, 20241713.33%460,56346.81%128.15%8-20.00%350.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF40.47K0.97%-13.02K
Abante Quant Value FI19.38K0.72%-1.00
Vanguard Total Stock Mkt Idx Inv16.86K0.56%-23.61K
Fidelity Extended Market Index11.49K0.43%4.85K
Vanguard Institutional Extnd Mkt Idx Tr9.45K0.35%-
NT Ext Equity Mkt Idx Fd - L3.09K0.11%3.02K
Spartan Total Market Index Pool G1.39K0.05%1.03K
Fidelity Series Total Market Index1.34K0.05%-
NT Ext Eq Mkt Indx Fd DC Lending Tier 51.21K0.04%1.19K
Fidelity Total Market Index915.000.03%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 23, 2025Foster Jonathan P. Chief Financial OfficerBuy$100.00K
Jun 23, 2025Foster Jonathan P. Chief Financial OfficerSell$300.00K
Jun 23, 2025KLEMP WALTER V CEO and PresidentSell$750.00K
Jun 23, 2025KLEMP WALTER V CEO and PresidentBuy$250.00K
Dec 26, 2023Foster Jonathan P. Chief Financial OfficerBuy$20.00K

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q24-
2024 Q4--
2024 Q3--
2024 Q2--

MBRX Ownership FAQ

Who Owns Moleculin Biotech?

Moleculin Biotech shareholders are primarily institutional investors at 3.69%, followed by 2.24% insiders and 94.07% retail investors. The average institutional ownership in Moleculin Biotech's industry, Biotech Stocks , is 381.47%, which Moleculin Biotech falls below.

Who owns the most shares of Moleculin Biotech?

Moleculin Biotech’s largest shareholders are Rockefeller capital management (14.51K shares, 0.09%), Tower research capital llc (trc) (8.38K shares, 0.05%), and Advisor group (43 shares, 0.00%). Together, they hold 0.15% of Moleculin Biotech’s total shares outstanding.

Does Blackrock own Moleculin Biotech?

BlackRock is not among the top 10 institutional shareholders of Moleculin Biotech.

Who is Moleculin Biotech’s biggest shareholder by percentage of total assets invested?

Tower research capital llc (trc) is Moleculin Biotech’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 8.38K Moleculin Biotech shares, valued at 4.44K$.

Who is the top mutual fund holder of Moleculin Biotech shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Moleculin Biotech shares, with 0.97% of its total shares outstanding invested in 40.47K Moleculin Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools